Victoria Gemme is a director based in Washington, D.C., focused on federal health care policy issues related to the U.S. Food and Drug Administration (FDA).
Victoria brings more than a decade of experience in health care and legislative and regulatory policy, including in the rare disease space. She most recently served as director of policy and regulatory affairs at the National Organization for Rare Disorders (NORD), where she led policy development and advocacy strategy to advance research, drug development, and health care access for individuals living with rare diseases.
She previously served as assistant research director at Duke-Margolis Institute for Health Policy, overseeing a multi-million-dollar cooperative agreement with the FDA to support regulatory research and convenings related to the Prescription Drug User Fee Act (PDUFA). Prior to her time at Duke-Margolis, Victoria worked for the Cystic Fibrosis Foundation managing a policy portfolio covering basic science research and drug development, among other topics.
Victoria earned a Master of Business Administration from Quantic School of Business and Technology, a master’s degree in Ethics and Public Policy from Suffolk University, and a bachelor’s degree in Neuroscience from Vassar College.